direct medical costs of breast cancer in Iran: analyzing the patient's level data from a cancer specific hospital in Isfahan

Breast cancer is one of the main causes of mortality and morbidity world-wide. The estimation of the direct medical costs of breast cancer can help payers of the cost to understand the burden of breast cancer on their limited financial resources as well as the society. We used a cross-sectional study to calculate the direct medical costs of breast cancer among women in Isfahan, Iran. The medical records of all patients which were registered in Seyed Al-Shohada Hospital between March 2005 and March 2010 were reviewed. The relevant data from patients' profiles extracted. The direct medical costs of received services were calculated with both public and private tariffs. The total numbers of 467 patients in various disease stages were included into the study. The average age of patients was 49 years. The average direct cost per patient per month in stages I to IV were 222.17, 224.61, 316.51 and 828.52 US$, respectively. The surgery cost was the main cost driver for stages I and II with private tariffs. However for stages III and IV, the medication cost was the main cost component for managing breast cancer. The direct economic cost of breast cancer in Iran is very high; nonetheless, as the age of breast cancer in Iran is nearly 10 years lower than Western countries, the burden of the disease in Iran is expected to be significantly high. Medication therapy is the main cost component of the breast cancer

direct medical costs of colorectal cancer in Iran; analyzing the patient's level data from a cancer specific hospital in Isfahan

The Immense cost of cancer treatment is one of the main challenges of health care systems all over the world including Iran. The aim of this study was to analyze the direct treatment costs of colorectal cancer patients in Isfahan, Iran. In this cross sectional study, the medical records of colorectal cancer [CRC] patients admitted to the Seyyed-al-Shohada Hospital "SSH" from 2005-2010 were reviewed. The profiles of 452 patients were examined. However based on inclusion, exclusion criteria a total number of 432 profiles were analyzed. All records including age, sex, treatment processes and treatment costs were extracted from the patients' profiles and analyzed using Kruskal-Wallis test. The results showed that 56.1% of CRC patients were male. The mean age of patients suffering from CRC was 56 +/- 13.4. More than Thirty-six percent of the patients were in stages 1-3 of CRC and more than half of them [64.4%] were in the 4[th] stage. The higher the stage of the cancer the higher the percentage of treatments used. 5-Fluorouracil and Leucovorin [5FU/LV] was the most common used chemical treatment protocol. The mean treatment cost for stage one was 10715 [ +/- 4927], for stage two 15920 [ +/- 3440], stage three 16452 [ +/- 2828] and for stage four was 16723 [ +/- 2555] US Dollars. The cost of drug treatment was the first cost driven between the medical services. CRC in Iranian population starts in younger age than people in western countries. This imposed considerable direct and indirect economic cost to the society. The direct medical cost of colorectal cancer in Iran is very higher than 38 million [dollar sign]. Screening programs could reduce the economic cost of CRC significantly

Microencapsulation of matricine by a dehydrating liquid and assessment of its retention

Matricine of flowers of cultivated Matricaria chamomilla L. was isolated and identified by TLC, IR, UV and 1H-NMR and quantified by HPLC. One of the lopophylic materials of this plant [matricine] has been used as antispasmodic and anti-inflammatory. Retention of matricine by microencapsulation technique was one of the objectives of this study. Encapsulation was carried out by cold dehydrating liquid method and effects of the various process parameters on retention of the matricine were evaluated. To achieve high retention values it was necessary to employ low core to shell material ratio, high solid concentration, high viscosity of the emulsion continuous phase, the use of absolute ethanol as desiccant, short contact times between capsules and desiccant, and low air pressure in the formation of microcapsules. Results suggested that the process might be much more efficient if continuous coextrusion of the emulsion and desiccant were used